TY  - JOUR

T1  - P-676 Long-term therapy with zoledronic acid is effective and safe in reducing the risk of skeletal complications in patients with bone metastases from non-small cell lung cancer

JO  - Lung Cancer

PY  - 2003/08/01

AU  - Bukowski R

AU  - Rosen LS

AU  - Gordon D

AU  - Tchekmedyian S

AU  - Hirsh V

AU  - Yanagihara R

AU  - Coleman RE

ED  - 

DO  - DOI: 10.1016/s0169-5002(03)92643-2

PB  - Elsevier BV

VL  - 41

SP  - S262

EP  - S263

Y2  - 2025/10/10

ER  -